Related Experiment Video
Updated: May 6, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
Published on: December 29, 2021
Anticonvulsant Potential of the Essential Oil of Croton Heliotropiifolius Kunth: In Vivo and In Silico Approach
Maria Elane S da Cunha1, Angélica L Soares2, Esdras M S Lima2
1Postgraduate Program in Chemistry, State University of Piaui, Teresina, Piauí 64002-150, Brazil.
Abstract:
Epilepsy is a chronic condition that significantly impacts the quality of life of many individuals, underscoring the urgent need for the identification of safe and effective anticonvulsant agents. In this context, medicinal plants have emerged as a promising source of bioactive compounds for treating epilepsy. This study involved an in vivo and in silico investigation of the anticonvulsant activity of the essential oil from the leaves of Croton heliotropiifolius Kunth (OCH). In vivo experiments revealed that the essential oil promoted a significant increase in seizure latency and survival rate in animals treated with OCH at a dose of 200 mg/kg, indicating an anticonvulsant effect. To understand the possible receptors and sites of action of the compounds in the oil, we performed a molecular docking study with GABAA and NMDA receptors. Additionally, we calculated the electronic properties of the phytoconstituents at the B3LYP/6-311++G-(d,p)/SMD level. The results of the molecular docking studies revealed that the sesquiterpenes α-bulnesene, δ-cadinene, and β-bourbonene, which are present in OCH, have a high affinity for the GABAA receptor, with binding energies ranging from -10.0 to -9.1 kcal/mol. These compounds primarily interact with the receptors through hydrophobic forces, highlighting the importance of interaction with Phe77 of the γ2-(E) subunit of GABAA. Docking analysis of NMDA revealed a higher affinity for the sesquiterpene guaiadiene, with a binding energy of -8.0 kcal/mol. Molecular dynamics simulations indicate that the α-bulnesene-GABAA and guaiadiene-NMDA complexes remained stable over 100 ns. DFT analysis revealed that the most promising ligands are more stable and have moderate to strong electrophilicity. This research provides valuable insights for the identification of new molecules in the development of herbal medicines for the treatment of epilepsy, suggesting that the anticonvulsant effect of OCH may be related to the modulation of the GABAA receptor or NMDA.
More Related Videos
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

